Therapeutic vanish in pyogenic granuloma: a case series


  • Deepthi Ravishankar Department of Dermatology, J.J.M. Medical College, Davangere, Karnataka, India
  • Mamatha S. Kusagur Department of Dermatology, J.J.M. Medical College, Davangere, Karnataka, India



Pyogenic granuloma, Sclerotherapy, Sodium tetradecyl sulphate


Pyogenic granuloma (PG) is a common benign vascular tumour which affect both skin and mucous membranes, occurring commonly on the face, oral mucosa, or a site of previous injury in all ages. Though some PGs resolve spontaneously, most requires treatment to prevent bleeding, ulceration, and scarring. We presented a case report of 4 patients who developed PG on index finger, forehead and nose. Our findings demonstrated the use of sclerotherapy using 3% sodium tetradecyl sulphate which is a safe and economical therapy for adult patients.


Requena L, Sangueza OP. Cutaneous vascular proliferations, part II: hyperplasias and benign neoplasms. J Am Acad Dermatol. 1997;37:887-920.

Yang C, Liu S. Treatment of giant pyogenic granuloma with the Nd/YAG holmium laser: a case report. J Cosmet Laser Ther. 2013;15:225-7.

Millsop JW, Trinh N, Winterfield L, Berrios R, Hutchens KA, Tung R. Resolution of Recalcitrant Pyogenic Granuloma with laser, corticosteroid, and timolol therapy. Dermatol Online J. 2014;20(3).

Gilmore A, Kelsberg G, Safranek S. Clinical inquiries. What's the best treatment for pyogenic granuloma? J Fam Pract. 2010;59(1):40-2.

Khaitan T, Sinha R, Sarkar S, Kabiraj A, Ramani D, Sharma M. Conservative approach in the management of oral pyogenic granuloma by sclerotherapy. J Indian Acad Oral Med Radiol. 2018;30(1):46.

Reddy GS, Reddy GV, Reddy KS, Priyadarshini BS, Sree PK. Intralesional sclerotherapy – A novel approach for the treatment of intraoral haemangiomas. J Clin Diagn Res. 2016;10:ZD13.

Ross M, Pawlina W. Inflammation. In: Ross M, Pawlina W, eds. Histology: A Text and Atlas: with Correlated Cell and Molecular Biology. 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2001: 158-178.

Neville BW, Damm DD, Allen CM, Bouquot JE. Pyogenic granuloma. In: Neville BW, Damm DD, Allen CM, Bouquot JE, eds. Oral and Maxillofacial Pathology. 3rd ed. Philadelphia Elsevier; 2009: 447- 449.

Parisi E, Glick PH, Glick M. Recurrent intraoral pyogenic granuloma with satellitosis treated with corticosteroids. Oral Dis. 2006;12:70-2.

Piraccini BM, Bellavista S, Misciali C, Tosti A, de Berker D, Richert B. Periungual and subungual pyogenic granuloma. Br J Dermatol. 2010;163(5):941-53.

Deore GD, Gurav AN, Patil R, Shete AR, NaikTari RS, Khiste SV et al. Sclerotherapy: A novel bloodless approach to treat recurrent oral pyogenic granuloma associated with port-wine stain. Ann Vasc Surg. 2014;28(6):1564-9.

Hong SK, Lee HJ, Seo JK, Lee D, Hwang SW, Sung HS. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy. Dermatol Surg. 2010;36:1148-52.

Sacchidanand S, Purohit V. Sclerotherapy for the treatment of pyogenic granuloma. Indian J Dermatol. 2013;58:77-8.

Moon SE, Hwang EJ, Cho KH. Treatment of pyogenic granuloma by sodium tetradecyl sulphate sclerotherapy. Arch Dermatol. 2005;141(5):644-6.

Rahman H, Hadiuzzaman. Pyogenic granuloma successfully cured by sclerotherapy: A case report. J Pakistan Assoc Dermatologists. 2014;24(4):361-4.

Kiran R, Asad F, Haider S, Bashir B, Rani Z, Khurshid K, et al. Efficacy of sclerotherapy with sodium tetradecyl sulphate in the treatment of pyogenic granuloma. J Pakistan Assoc Dermatologists. 2017;27(2):110-3.






Case Series